Literature DB >> 23903335

The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.

James T R Walters1, Dan Rujescu, Barbara Franke, Ina Giegling, Alejandro Arias Vásquez, April Hargreaves, Giancarlo Russo, Derek W Morris, Martine Hoogman, Andrea Da Costa, Valentina Moskvina, Guillén Fernández, Michael Gill, Aiden Corvin, Michael C O'Donovan, Gary Donohoe, Michael J Owen.   

Abstract

OBJECTIVE The authors investigated the effects of recently identified genome-wide significant schizophrenia genetic risk variants on cognition and brain structure. METHOD A panel of six single-nucleotide polymorphisms (SNPs) was selected to represent genome-wide significant loci from three recent genome-wide association studies (GWAS) for schizophrenia and was tested for association with cognitive measures in 346 patients with schizophrenia and 2,342 healthy comparison subjects. Nominally significant results were evaluated for replication in an independent case-control sample. For SNPs showing evidence of association with cognition, associations with brain structural volumes were investigated in a large independent healthy comparison sample. RESULTS Five of the six SNPs showed no significant association with any cognitive measure. One marker in the major histocompatibility complex (MHC) region, rs6904071, showed independent, replicated evidence of association with delayed episodic memory and was significant when both samples were combined. In the combined sample of up to 3,100 individuals, this SNP was associated with widespread effects across cognitive domains, although these additional associations were no longer significant after adjusting for delayed episodic memory. In the large independent structural imaging sample, the same SNP was also associated with decreased hippocampal volume. CONCLUSIONS The authors identified a SNP in the MHC region that was associated with cognitive performance in patients with schizophrenia and healthy comparison subjects. This SNP, rs6904071, showed a replicated association with episodic memory and hippocampal volume. These findings implicate the MHC region in hippocampal structure and functioning, consistent with the role of MHC proteins in synaptic development and function. Follow-up of these results has the potential to provide insights into the pathophysiology of schizophrenia and cognition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903335     DOI: 10.1176/appi.ajp.2013.12020226

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 2.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

Review 3.  [Neurobiology of schizophrenia: new findings from the structure to the molecules].

Authors:  A Schmitt; B Malchow; D Keeser; P Falkai; A Hasan
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

Review 4.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

5.  Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder.

Authors:  Huijuan Li; Hong Chang; Xueqin Song; Weipeng Liu; Lingyi Li; Lu Wang; Yongfeng Yang; Luwen Zhang; Wenqiang Li; Yan Zhang; Dong-Sheng Zhou; Xingxing Li; Chen Zhang; Yiru Fang; Yan Sun; Jia-Pei Dai; Xiong-Jian Luo; Yong-Gang Yao; Xiao Xiao; Luxian Lv; Ming Li
Journal:  Neuropsychopharmacology       Date:  2019-02-16       Impact factor: 7.853

6.  Genetic associations with childhood brain growth, defined in two longitudinal cohorts.

Authors:  Eszter Szekely; Tae-Hwi Linus Schwantes-An; Cristina M Justice; Jeremy A Sabourin; Philip R Jansen; Ryan L Muetzel; Wendy Sharp; Henning Tiemeier; Heejong Sung; Tonya J White; Alexander F Wilson; Philip Shaw
Journal:  Genet Epidemiol       Date:  2018-04-22       Impact factor: 2.135

Review 7.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

8.  Regional enrichment analyses on genetic profiles for schizophrenia and bipolar disorder.

Authors:  Jingyu Liu; Jiayu Chen; Nora I Perrone-Bizzozero; Jessica A Turner; Vince D Calhoun
Journal:  Schizophr Res       Date:  2017-04-22       Impact factor: 4.939

Review 9.  Imaging genetics and psychiatric disorders.

Authors:  R Hashimoto; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; S Umeda-Yano; Y Watanabe; M Fukunaga; M Takeda
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

Review 10.  Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease.

Authors:  Jonathan Flint; Nicholas Timpson; Marcus Munafò
Journal:  Trends Neurosci       Date:  2014-09-09       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.